AI & Competitive Intelligence in Pharma: Smarter Decision-Making with SAI MedPartners
In this episode of the IDEA Collider podcast, industry experts explore the evolving role of AI in Competitive Intelligence (CI) in pharmaceutical and biotech strategy — and how organizations can move beyond data collection to drive smarter, more confident decision-making. Featuring insights from Erik Nordhoy, CEO of SAI MedPartners, alongside his team, John Barry, Matt Boucher, Jennifer Preston, and Lucia Fernandez Barreiros, this conversation examines how cross-functional teams can interpret insights, manage uncertainty, and improve portfolio outcomes in complex drug development environments. The discussion covers artificial intelligence, asymmetric learning, forecasting challenges, strategic alignment, and the leadership mindset required to navigate innovation in biopharma. SAI MedPartners is a global consultancy that provides strategic insights, competitive intelligence, market research, and commercialization strategy to pharmaceutical, biotechnology, and medical device companies across the product lifecycle. This episode is a must-listen for leaders working across drug development, commercialization strategy, and pharmaceutical innovation. Keep up with the guests; Erik Nordhoy - President at SAI MedPartners LLC https://www.linkedin.com/in/erik-nordhoy-6996241/ John Barry - Executive Vice President at SAI MedPartners LLC https://www.linkedin.com/in/johnnbarry/ Matt Boucher, PhD - Director, Oncology BU, SAI MedPartners LLC https://www.linkedin.com/in/matthewbchr/ Jennifer Preston - VP, Artificial Intelligence Leader, SAI MedPartners LLC https://www.linkedin.com/in/jennifer-j-preston/ Lucia Fernandez Barreiros - Consulting Analyst, SAI MedPartners LLC https://www.linkedin.com/in/lucia-fernandez-barreiros-ba5260224/ Follow Mike Rea On; Website: https://ideacollider.simplecast.com/ X: https://x.com/ideapharma LinkedIn: https://www.linkedin.com/in/bigidea/ Listen to more fantastic podcast episodes: https://ideacollider.simplecast.com/
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from IDEA Collider: Innovation & Asymmetric Learning in Pharma
The Keytruda Blueprint: Alex Gray, David Radwaner, and Tom Brockbank on the IO Revolution
Scaling TCR-T Therapies: Reagan Jarvis on Non-Viral Gene Editing and Target Mapping
Vir Biotechnology: Marianne De Backer on Immuno-Oncology, Hepatitis Delta, and Biotech Turnarounds
Building the Future of Targeted Protein Degradation Medicines with Nello Mainolfi
Get summaries like this every morning.
Free AI-powered recaps of IDEA Collider: Innovation & Asymmetric Learning in Pharma and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.